Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarinic receptor antagonists

Details for Australian Patent Application No. 2007321019 (hide)

Owner AstraZeneca AB

Inventors Ford, Rhonan; Mete, Antonio; Mather, Andrew

Agent Freehills

Pub. Number AU-B-2007321019

PCT Pub. Number WO2008/059245

Priority 60/869,384 11.12.06 US; 60/865,667 14.11.06 US

Filing date 13 November 2007

Wipo publication date 22 May 2008

Acceptance publication date 21 April 2011

International Classifications

C07D 453/02 (2006.01) Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

Event Publications

21 May 2009 PCT application entered the National Phase

  PCT publication WO2008/059245 Priority application(s): WO2008/059245

21 April 2011 Application Accepted

  Published as AU-B-2007321019

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007321070-Methods and uses involving genetic abnormalities at chromosome 12

2007321018-Preparation of tissue for meniscal implantation